General Description
High levels of serum autoantibodies against deoxyribonucleic acid (DNA) are observed in most patients with systemic lupus erythematosus (SLE) (1, 2), therefore the presence of anti-DNA antibodies in serum is considered a valuable marker for the diagnosis of SLE. Moreover, the serum anti-DNA antibodies form anti-DNA/DNA immune complexes which play an important role in the immunopathogenesis of lupus nephritis caused by SLE (3). Anti-single stranded DNA (ssDNA) IgG antibodies are elicited in the early stages of SLE, whereas anti-double stranded DNA (dsDNA) IgG antibody levels correlate with the severity of SLE. On the other hand, anti-dsDNA lgM antibodies are not specific to SLE, but correlate with the prognosis of lupus nephritis in patients with SLE (4, 5). Therefore, evaluating immunoglobulin levels of different isotypes against individual DNA types may signify a particular stage and the prognosis of SLE.
Mouse SLE models, which translate relevant information to the human condition, elucidate the cellular and genetic requirements. For example, in spontaneous mouse NZB/W F1 lupus models, anti-dsDNA antibody isotype class switching from lgM to IgG indicates renal failure which is observed in human SLE (6). Nonetheless, in artificial pristane-induced Balb/c lupus models, anti-ssDNA lgM antibodies solely induce SLE (7-9). Therefore, to study the diverse roles of anti-DNA antibodies in these mouse SLE models, Creative Diagnostics, Inc. provides anti-dsDNA lgM (Catalog # DEIA-PY07130) antibody ELISA kits.